UK markets closed

Oramed Pharmaceuticals Inc. (ORMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3000-0.0300 (-1.29%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1120
Avg. Estimate-0.02-0.03-0.260
Low estimate-0.02-0.03-0.410
High estimate-0.02-0.03-0.110
Year ago EPS-0.03-0.080.14-0.26
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1121
Avg. Estimate500k500k1.3MN/A
Low estimate500k500k600kN/A
High estimate500k500k2MN/A
Year ago sales674kN/A1.34M1.3M
Sales growth (year/est)-25.80%N/A-3.00%N/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.1-0.08-0.120.02
Actual EPS-0.03-0.080.330.04
Difference0.0700.450.02
Surprise %70.00%0.00%375.00%100.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.02-0.03-0.260
7 days ago-0.02-0.03-0.26-1.08
30 days ago-0.02-0.03-0.26-1.08
60 days ago-0.02-0.03-0.26-1.08
90 days ago-0.02-0.03-0.26-1.08
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesORMPIndustrySector(s)S&P 500
Current qtr.33.30%N/AN/AN/A
Next qtr.62.50%N/AN/AN/A
Current year-285.70%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A